Suresh Agarwal, PhD

Director, Clinical Pharmacology
BioMarin Pharmaceuticals Inc.
Novato, California, United States

Presentation(s):

• PB0626 - Quantitative pharmacokinetic model to characterize and extrapolate long-term FVIII activity levels in patients with severe hemophilia A treated with valactocogene roxaparvovec

  Monday, June 26, 2023
  18:30 – 19:30 ET